(Q87263473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

3

Richard L Apodaca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

John M Keith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Natalie Hawryluk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Allison Chambers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Joan M Pierce

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mark Seierstad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

James A Palmer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Michael Webb

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mark J Karbarz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Brian P Scott

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sandy J Wilson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Lin Luo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Michelle L Wennerholm

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Leon Chang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Michele Rizzolio

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sandra R Chaplan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J Guy Breitenbucher

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

31 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1280-1284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate

7 March 2020

cites work

2 references

https://opencitations.net/index/api/v1/citations/10.1021/ML300186G

1 August 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase

1 August 2024

2 references

https://opencitations.net/index/api/v1/citations/10.1016/J.BMCL.2008.07.081

1 August 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase

1 August 2024

2 references

https://opencitations.net/index/api/v1/citations/10.1213/ANE.0B013E31818C7CBD

1 August 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase

1 August 2024

2 references

https://opencitations.net/index/api/v1/citations/10.1021/JM0611509

1 August 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Binding and Inactivation Mechanism of a Humanized Fatty Acid Amide Hydrolase by α-Ketoheterocycle Inhibitors Revealed from Cocrystal Structures

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

The palmitoylethanolamide family: a new class of anti-inflammatory agents?

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

Fatty acid amide hydrolase substrate specificity

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMCL.2014.01.064

10.1016/J.BMCL.2014.01.064

1 August 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513048%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference